Trial Profile
Combined Radiotherapy and Sorafenib in Patients With Hepatoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Mar 2011 New trial record